Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 27 Jan 2015 |
| Trading by management and of close relations to management | 23 Jan 2015 |
| Group financial statement for 2014 | 20 Jan 2015 |
| The Novozymes Report 2014 | 20 Jan 2015 |
| Novozymes A/S’ stock buyback program completed | 11 Dec 2014 |